To access this element change to forms mode OFF
Grant Award View - GA217016
Cardiovascular Screening in Cancer Patients Treated with Immune...
GA ID:
GA217016
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
17-Oct-2021
Publish Date:
7-Feb-2022
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2025
Value (AUD):
$136,151.84
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Postgraduate Scholarships
Grant Activity:
Cardiovascular Screening in Cancer Patients Treated with Immune Checkpoint Inhibitors
Purpose:
Patients with cancer treated with immunotherapy are at higher risk of cardiovascular disease. As cancer survival with immunotherapy is improving, it is important to address cardiovascular risk and screening in cancer patients to reduce the burden of cardiovascular disease and improve overall survivorship. We aim to evaluate cardiovascular risk and guide screening policies that could help prevent cardiovascular disease in cancer patients receiving immunotherapy.
GO ID:
GO Title:
2021 NHMRC Postgraduate Scholarship scheme
Internal Reference ID:
2021/GNT2014112
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Monash University
Recipient ABN:
12 377 614 012
Grant Recipient Location
Suburb:
Clayton
Town/City:
Clayton
Postcode:
3800
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW, VIC
Postcode:
Multiple
Country:
AUSTRALIA